John Mark O'Mahony

Insider Reports History

Entity
Individual
Location
C/O Leap Therapeutics, Inc., 47 Thorndike Street, Suite B1 1, Cambridge, MA
Signature
/s/ Douglas E. Onsi, as attorney-in-fact for John Mark O'Mahony
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Mark O'Mahony:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LEAP THERAPEUTICS, INC. Chief Manufacturing Officer Common Stock 5K $14.3K $2.85 Jan 26, 2024 Direct
LEAP THERAPEUTICS, INC. Chief Manufacturing Officer Restricted Stock Units 0 $0 $2.85 Jan 26, 2024 Direct
LEAP THERAPEUTICS, INC. Chief Manufacturing Officer Employee Stock Option (Right to Buy) 85K Oct 2, 2024 Direct
LEAP THERAPEUTICS, INC. Chief Manufacturing Officer Employee Stock Option (Right to Buy) 85K Jan 29, 2024 Direct

Insider Reports Filed by John Mark O'Mahony

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LPTX LEAP THERAPEUTICS, INC. Oct 2, 2024 1 $0 4 Oct 4, 2024 Chief Manufacturing Officer
LPTX LEAP THERAPEUTICS, INC. Jan 29, 2024 1 $0 4 Jan 31, 2024 Chief Manufacturing Officer
LPTX LEAP THERAPEUTICS, INC. Jan 26, 2024 2 $0 4 Jan 30, 2024 Chief Manufacturing Officer
LPTX LEAP THERAPEUTICS, INC. Aug 23, 2023 1 $0 4 Aug 25, 2023 Chief Manufacturing Officer
LPTX LEAP THERAPEUTICS, INC. Mar 31, 2023 1 $0 4 Apr 4, 2023 Chief Manufacturing Officer
LPTX LEAP THERAPEUTICS, INC. Sep 1, 2022 1 $0 4 Sep 2, 2022 Chief Manufacturing Officer
LPTX LEAP THERAPEUTICS, INC. Jan 31, 2022 1 $0 4 Feb 2, 2022 Chief Manufacturing Officer
LPTX LEAP THERAPEUTICS, INC. May 26, 2021 1 $0 4 May 28, 2021 Chief Manufacturing Officer